NEW ORLEANS, May 21, 2013 — The Muscular Dystrophy Association announced today the designation of the Louisiana State University Health Sciences Center New Orleans School of Medicine as an MDA/ALS clinic.
TARRYTOWN, N.Y. and TUCSON, Ariz., April 17, 2013 — ARMGO Pharma and the Muscular Dystrophy Association (MDA) today announced that $1 million has been awarded for preclinical work in support of an investigational new drug (IND) application with the U.S.
TUCSON, Ariz., Feb. 14, 2013 — The Muscular Dystrophy Association, Parent Project Muscular Dystrophy and the Foundation to Eradicate Duchenne today called on the U. S. Senate and the U. S. House of Representatives to reauthorize the MD CARE Act of 2001, and to continue federal support for the accelerated pace of research and treatment development for muscular dystrophy.
TUCSON, Ariz. — The Muscular Dystrophy Association announced today that it has awarded a $400,000 infrastructure grant to National Institutes of Health (NIH) researchers to support exome sequencing on samples taken from 1,000 people with amyotrophic lateral sclerosis (ALS).
TUCSON, Ariz., Aug. 21, 2012 — Greater understanding of the causes and natural histories of neuromuscular diseases, and translation of the latest research advances into potential treatments are the focus of new projects funded by the Muscular Dystrophy Association’s latest round of grants.